National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

RIVM is preparing for implementation of the coronavirus vaccinations. As soon as there is a safe and effective vaccine against the novel coronavirus, it will be quickly and carefully deployed to vaccinate the target groups.

In the past week, the Municipal Health Services (GGDs) reported 36,931 new reports of confirmed COVID infections. This is about the same as in the previous week, when 37,706 new COVID-19 infections were reported (-2%).

For the second week in a row, the number of newly reported COVID-19 infections decreased last week compared to the week before that.

The number of newly reported COVID-19 infections decreased last week compared to the week before that. The number of newly reported infections is dropping in all regions.

Starting this week, the measurement results from the sewage research in various municipalities and security regions can be compared on the Coronavirus Dashboard.

The number of newly reported COVID-19 infections decreased slightly last week compared to the week before that. Reproduction number R is still entirely above 1.

Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.

This spring, about 860,000 young people in the Netherlands will receive an invitation for a vaccination against meningococcal disease.